Which has grown faster, ARWR or TGTX?

Over the past five years, TGTX grew revenue faster — ARWR at a 44.14% CAGR versus TGTX at 219.22%.

Is ARWR or TGTX more profitable?

TGTX runs the higher net margin — ARWR at -47.79% versus TGTX at 55.22%.

How have ARWR and TGTX total returns compared?

Over the past 10 years, ARWR delivered 23.56% and TGTX delivered 20.46% annualized total return. Past performance doesn't predict future results.

Arrowhead Pharmaceuticals, Inc. (ARWR) vs TG Therapeutics, Inc. (TGTX)

A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and TG Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARWR

Arrowhead Pharmaceuticals, Inc.

$8.67B

$61.54HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TGTX

TG Therapeutics, Inc.

$7.99B

$52.19HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ARWR vs TGTX

growth of $100 · dividends reinvested · last 10y

ARWR +755.3% (+23.9%/yr)TGTX +540.3% (+20.4%/yr)ARWR compounded faster over this window

ARWR TGTX

ARWR vs TGTX: by the numbers

•ARWR is the larger company ($8.67B vs $7.99B market cap).
•TGTX is profitable (55.22% net margin) while ARWR runs a net loss (-47.79%).
•TGTX grew revenue faster over the past five years (219.22% vs 44.14% CAGR).

Metrics side by side

Valuation

Metric	ARWR	TGTX
P/E ratio	N/A	19.05
Forward P/E	N/A	53.62
P/S ratio	12.95	9.99
P/B ratio	18.62	13.23
EV / EBITDA	N/A	60.46
FCF yield	N/A	0.22%

Profitability

Metric	ARWR	TGTX
Gross margin	100.00%	82.36%
Operating margin	11.86%	17.05%
Net margin	-47.79%	55.22%
ROE	-68.73%	73.08%
ROIC	-12.12%	9.94%

Growth (annualized)

Metric	ARWR	TGTX
Revenue CAGR (5Y)	44.14%	219.22%
Total return CAGR (5Y)	0.75%	10.75%

Frequently asked

Which has grown faster, ARWR or TGTX?: Over the past five years, TGTX grew revenue faster — ARWR at a 44.14% CAGR versus TGTX at 219.22%.
Is ARWR or TGTX more profitable?: TGTX runs the higher net margin — ARWR at -47.79% versus TGTX at 55.22%.
How have ARWR and TGTX total returns compared?: Over the past 10 years, ARWR delivered 23.56% and TGTX delivered 20.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ARWR analysis Full TGTX analysis Interactive comparison tool

Dig into the metrics

TG Therapeutics P/E ratio Arrowhead Pharmaceuticals ROE TG Therapeutics ROE Arrowhead Pharmaceuticals operating margin TG Therapeutics operating margin Arrowhead Pharmaceuticals revenue growth TG Therapeutics revenue growth Arrowhead Pharmaceuticals free cash flow TG Therapeutics free cash flow

Arrowhead Pharmaceuticals & TG Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.